INTRODUCTION
Acute inflammation is characterized by swelling, heat, redness, and pain and is an important defense mechanism against invading pathogens. The mediators that arise from the cyclooxygenase (COX) cascade and role of biologically active prostaglandins in the inflammatory process and body homoeostasis have been extensively studied. Cyclooxygenase inhibitors prevent prostaglandin biosynthesis and are effective anti-inflammatory compounds that reduce the levels of prostaglandins and cardinal signs of inflammation. Neutrophil chemotaxis to sites of inflammation is an essential process during normal immune responses to tissue injury and infection. Phagocytes form an important front-line defense against infection and are a major part of innate immunity and the process of removing pathogens from the blood and tissue fluids [1] .
Anti-inflammatory drugs, such as steroids and nonsteroidal anti-inflammatory drugs, cause adverse effects, including gastric damage. The use of these drugs for their anti-inflammatory effects has not been successful in all cases. Hence, the search for natural products has increased. Camphor (C 10 H 16 O) is a natural and synthetic terpenoid ketone compound that is present in Cinnamomum camphora and other plant species [2] . It is a popular household remedy that is believed to act as an aphrodisiac, contraceptive, abortifacient, and lactation suppressor [3] . Camphor has been used topically to relieve pain and treat warts, cold sores, hemorrhoids, and osteoarthritis. It is a common ingredient in a wide variety of over-the-counter topical products [4] . The human lethal dose has been reported to be 50 -500 mg/kg [3] . However, the toxicity of camphor in rats is not considered to be high, with an LD 50 of 3000 mg/kg [5] .
Several studies have been performed with extracts of plants that contain camphor, demonstrating anti-inflammatory, antioxidative, and antimicrobial effects [6, 7] . However, very few studies have specifically evaluated the effects of camphor on the acute inflammatory response, hence the need for this study.
EXPERIMENTAL Chemicals
Camphor, Dexamethasone, Zymosan, LPS (lipopolysaccharides from Salmonella enterica serotype typhimurium), fMLP (N-formyl methionyl leucyl phenylalanine) and Cróton oil were purchased from Sigma-Aldrich (St. Louis, MO, USA).
Animals
Male Swiss mice, weighing 25 -30 g, were provided by the Central Animal House of the State University of Maringá, Maringá, Brazil. The animals were housed at 22 ± 2 o C under a 12/12 h light/dark cycle. Prior to the experiments, the animals were fasted overnight, with water provided ad libitum. The experimental protocols were approved by the Ethical Committee on Animal Experimentation of the State University of Maringá (CEAE/UEM 070/2012). The animals were handled according to the standard protocols for the use of laboratory animals [8] .
Cell viability analysis
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl-2H-tetrazolium bromide; Sigma) assay is based on the mitochondrial enzyme reduction of tetrazolium dye to detect and determine cell viability. Neutrophils were obtained from the peritoneal cavity of mice 4 h after zymosan injection (1 mg/cavity, i.p.). Briefly, the cells were plated at a density of 5 × 10 5 cells/well in a volume of 100 µl RPMI 1640 medium supplemented with 10 % fetal bovine serum (FBS) and 100 U/ml penicillin + 100 µg/ml streptomycin in 96-well plates. The cells were incubated with varying concentrations of camphor (3, 10, 30, and 90 µg/ml) at 37 °C in 5 % CO 2 for 90 min followed by the addition of 10 µl MTT (5 mg/ml) stock solution to each well. After 2 h of incubation at 37 o C, 150 µl of the supernatant was removed, and 100 µl dimethyl sulfoxide (DMSO) was added to each well. The cells were incubated at 25 °C for a further 10 min, and absorbance was measured using a Biochrom Asys Expert plus microplate reader at a wavelength of 540 nm. The values of the blank wells were subtracted from each well of treated and control cells. Viability was determined using Eq 1.
Viability (%) = {(At -Ab)/(Ac -Ab)}100 ……. (1) where At, Ab and Ac are the absorbance of treated cells, blank and control, respectively
Evaluation of in vitro neutrophil chemotaxis
To evaluate the effect of camphor on chemotaxis, neutrophils were obtained from the peritoneal cavity of mice by peritoneal wasing with 3 ml of phosphate-buffered saline (PBS) that contained ethylene-diaminetetraacetic acid (EDTA) 4 h after zymosan injection (1 mg/cavity, i.p.). The cell suspension was centrifuged at 1000 rpm for 10 min at 4 °C and resuspended in RPMI1640 medium [9] . The cell number was adjusted to 1 × 10 6 cells/ml in RPMI 1640 medium that contained 0.1 % bovine serum albumin (BSA). A chemotaxis assay was performed using a 48-well microchemotaxis plate (Neuro Probe), in which the chambers were separated by a polyvinylpyrrolidone-free polycarbonate membrane (5 µm pore size). The chemoattractant, N-formyl methionyl leucyl phenylalanine (fMLP; 10 -6 M), and vehicle (RPMI 1640) were placed in the lower chamber. A neutrophil suspension (1 × 10 6 cells/ml) was pretreated for 30 min with camphor (1, 3, 10, 30, 60, and 90 µg/ml) and then placed in the upper chamber. The chambers were incubated at 37 °C with 5 % CO 2 for 1 h. Following incubation, the membrane was washed in phosphate-buffered saline (PBS), fixed in methanol, and stained with Instant Prov. The membrane area of each well was scored using light microscopy to count the cells present in five random fields. The results are expressed as the mean number of neutrophils per field and are representative of triplicate measurements from three separate experiments.
Evaluation of camphor in topical ear edema inflammation model
Cutaneous inflammation was induced by the application of 5 % croton oil (10 µl) in acetone (vehicle) in the inner surface of the mouse right ear [9] . The left ear received an equal volume of vehicle. Camphor (0.5, 1, 2.5, and 5 mg/ear), dexamethasone (0.1 mg/ear, anti-inflammatory drug reference), or vehicle was applied topically to the right ear 1 h before croton oil application. The effect of oral camphor treatment was also studied. For oral treatment, the mice received camphor (100, 200, or 400 mg/kg) or dexamethasone (1 mg/kg, anti-inflammatory drug reference), diluted in hydroalcoholic vehicle that contained 2 % ethyl alcohol and 1 % Tween. Four hours after application of the inflammatory stimulus, the mice were euthanized with an anaesthetic overdose of ketamine/xylazine [10] , and a 7 mm diameter plug was removed from both the treated and untreated ears. Edema was measured as the weight difference between the two plugs. The data are expressed as the mean ± SEM weight of the ears.
Determination of myeloperoxidase activity
Myeloperoxidase (MPO) activity was assayed using homogenate supernatants of the ear sections (i.e., untreated controls and animals treated with camphor or dexamethasone) [9] . The ear sections were placed in 50 mM potassium phosphate buffer (pH 6.0) that contained 0.5 % hexadecyl trimethyl ammonium bromide (1 ml/50 mg of tissue; Sigma) in a Potter homogenizer. The homogenate was shaken in a vortex mixer and centrifuged for 5 min, and 10 µl of the supernatant was added to each well of a 96-well microplate in triplicate. Two hundred microliters of the buffer solution that contained 16.7 mg o-dianisidine dihydrochloride (Sigma), 90 ml double-distilled water, 10 ml potassium phosphate buffer, and 50 µl of 1 % H 2 O 2 were added. The enzyme reaction was stopped by the addition of sodium acetate. Enzyme activity was determined by absorbance measured at 460 nm using a microplate spectrophotometer (Spectra Max Plus).
Peritoneal macrophage preparation and determination of phagocytosis activity
To evaluate the effect of camphor on phagocytosis activity, macrophages were obtained from the peritoneal cavity of the mice.
To collect the macrophages, the animals were euthanized, and 5 ml PBS was injected intraperitoneally. Phosphate-buffered saline that contained peritoneal exudate cells was recollected and kept on ice. The suspended cells were centrifuged at 1500 rotations per minute for 10 min and resuspended with complete RPMI-1640. Peritoneal exudate cells were then isolated on 24-well culture plates and allowed to adhere for 1 h at 37 o C in 5 % CO 2 . After nonadherent cells were removed, the remaining adherent cells were designated as peritoneal macrophages. Cell viability, evaluated by the exclusion test with Trypan blue, was ≥ 90 % in all of the experiments. The cells were incubated for 24 h at 37 o C in 5 % CO 2 with different concentrations of camphor (3, 10, 30, or 90 µg/ml) in complete RPMI-1640 medium. Lipopolysaccharide (LPS; 20 µg/ml) was used as a positive control, and RPMI-1640 medium was used as a negative control. After incubation, 100 µl of a 3 % suspension of chicken red blood cells (CRBCs) was added to each well. CRBCs were used to assess macrophage phagocytosis. After 1 h, the macrophages were fixed and stained. Phagocytosis index was measured by counting the number of phagocytosed CRBCs per 100 macrophages [11] .
Statistical analysis
The data are expressed as mean ± SEM for each experimental group. The results were statistically analyzed using one-way analysis of variance (ANOVA) followed by Tukey's test. The software used was GraphPad Prism version 5.01, GrahPad Software, Inc. Differences were considered significant at p < 0.05.
RESULTS

Cell viability
In the cell viability assay, camphor was tested at different concentrations. Concentrations of 3, 10, 30, and 90 µg/ml presented cell viability of 82.5, 76, 85.8, and 88 %, respectively, indicating that camphor did not induce cell death when compared with the untreated cells.
Effect of camphor on in vitro neutrophil chemotaxis
To investigate the direct effect of camphor on leukocyte chemotaxis, different concentrations of camphor were tested (1, 3, 10, 30, 60, and 90 µg/ml) in the in vitro chemotaxis assay. fMLP was the chemotactic agent used to promote migration of neutrophils. The results obtained are shown in Figure 1 . MLP induced significant leukocyte migration compared to the vehicle (RPMI1640). Camphor at doses of 3, 10, and 30 µg/ml significantly reduced (p < 0.01) neutrophil migration toward fMLP (10 -6 M; 25.09 ± 0.89, 36.42 ± 1.07, and 23.53 ± 2.18 %, respectively), as illustrated in Figure 1 . 
Effect of camphor on the ear edema and MPO activity
Topical croton oil application in the right ear of mice induced an evident inflammatory response 4 h later, promoting ear edema formation. Topical camphor treatment did not reduce ear edema at any of the doses tested. In contrast, topical administration of dexamethasone as a reference drug significantly reduced ear edema by 59.6 % (p < 0.01; Figure 2A ). Topically administered camphor did not reduce MPO activity at any of the doses tested, whereas dexamethasone inhibited MPO activity by 61.32 % (p < 0.05; Figure 2B ). When camphor was administered orally by gavage, a reduction of ear edema was observed. Camphor treatment at doses of 100 and 200 mg/kg significantly reduced the intensity of edema by 59.4 and 49.8 %, respectively (p < 0.01), similar to the 64.3 % reduction induced by dexamethasone (1 mg/kg; p < 0.01). Camphor at a dose of 400 mg/kg increased ear edema by 21 % ( Figure 2C) . Additionally, the results demonstrated that oral treatment with camphor significantly reduced MPO activity by 51.5 and 60.6 % at doses of 100 and 200 mg/kg, respectively (p < 0.01), dexamethasone (1 mg/kg) significantly inhibited MPO activity by 57.6 % (p < 0.01). Camphor, at a dose of 400 mg/kg, increased MPO activity by 21 % ( Figure 2D ).
Effect of camphor on the phagocytic activity of macrophages
Camphor did not exert any influence on the phagocytic activity of macrophages (Figure 3 ).
Figure 3:
Effect of CAN on phagocytosis of macrophages. Macrophages were obtained from the peritoneal cavity of mice and treated with different doses of CAN (3, 10, 30 and 90 µg/ml). LPS at 20 µg/ml was used as positive control. *p < 0.05 versus NC (negative control), #p < 0.05, compared to the NC (ANOVA, Tukey's test)
DISCUSSION
Polymorphonuclear leukocyte recruitment is known to be an essential factor in the acute inflammatory process by acting as first-line defense cells in the initiation and resolution phases of this process, involving the participation of many inflammatory mediators, such as prostanoids.
In vitro treatment with camphor did not affect the viability of neutrophils at any of the concentrations tested, indicating that the direct effect of camphor on leukocyte chemotaxis inhibition did not occur because of toxic effects that induce cell death.
Studies performed with extracts and essential oils of Artemisia fukudo and Cinnamomum camphora that contain camphor as a major constituent found that they inhibited proinflammatory cytokines, such as interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and prostaglandin E2 (PGE2) in macrophage cultures [13, 14] . Indeed, camphor as an isolated compound inhibited the production of IL-1β, IL-4, and TNF-α [12] . Our data suggest that camphor may act by inhibiting proinflammatory cytokines induced by chemotactic agents. fMLP is a chemotactic agent involved in the release of many cytokines upon binding to its G-protein-coupled receptor, activating multiple signaling cascades [13] . These pathways include the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI-3K) cascades, which are important for the development of the functional responses of neutrophils in inflammation. Further studies should be performed to elucidate the anti-inflammatory mechanism of action of camphor.
To demonstrate the topical effect of camphor in vivo, we evaluated inflammatory ear edema induced by croton oil. This oil is an irritant that induces an inflammatory response by activating phospholipase A2 and initiating arachidonic acid metabolites [14] , followed by COX-1-and COX-2-induced prostaglandin production and 5-lipoxygenase-induced leukotriene production. Prostaglandins and leukotrienes are inflammatory mediators involved in edema and leukocyte migration.
MPO enzyme is found in the azurophilic granules of neutrophils and other cells of myeloid origin. It catalyzes the production of hypochlorous acid (which has toxic effects on microorganism) from hydrogen peroxide and chloride, but it is harmful to tissue cells [15] . Myeloperoxidase is an indirect marker of neutrophil infiltration into tissue. Decreases in MPO activity suggest less neutrophil infiltration. Our data suggest that camphor exerts anti-inflammatory effects only when administered systemically. At higher doses (e.g., 400 mg/kg), camphor has irritative effects. Oral dexamethasone administration inhibited phospholipase A2, consequently reducing eicosanoid production. Based on our results, we suggest that camphor inhibits chemotactic mediators that are released through different metabolic pathways. Our data showed that camphor effectively inhibited in vitro chemotaxis and leukocyte infiltration and had antiedematogenic activity when administered systemically.
Macrophages are phagocytic cells that play a central role in the immune response to inflammatory and infectious diseases. Lipopolysaccharide (LPS) is a major component of the outer membrane of Gram-negative bacteria and acts as one of the most powerful activators of resident macrophages by binding the CD14/toll-like receptor 4 (TLR-4)/MD2 receptor complex, leading to the activation of nuclear factor κB (NF-κB) and MAPKs, which not only promote the overproduction of cytokines, pro-inflammatory mediators, and phagocytosis but also induce the differentiation and maturation of monocytes/macrophages [16, 17] . As an activator of macrophages, LPS is one of the most potent microbial initiators of inflammation, which can increase the secretion of NO in mouse peritoneal macrophages [16] . The stimulation of TLR-4 receptors by LPS results in a significant increase in the production of pro-inflammatory cytokines, such as IL-6 and TNF-α [18] . The rate and index of CRBC phagocytosis were positively correlated with the expression of TLR-4 [19] .
NO is an inflammatory mediator secreted by macrophages that also increases macrophage activity [16, 20] . Cinnamomum camphora and Ocotea odorifera extracts and their essential oils, which contain camphor, exhibit antioxidative activity [6] , inhibiting free radical formation, such as NO and reactive oxygen species, and likely contributing to anti-inflammatory activity. Since camphor did not significantly alter the phagocytosis index at any of the concentrations tested, we suggest that camphor, as an isolated compound, is unlikely to be involved in the production of free radicals (e.g., NO) or pathways involved in the activation of TLR-4.
CONCLUSION
The results obtained show that camphor affects inflammatory response, inhibits neutrophil migration in vitro, has antiedematogenic activity, and decreases neutrophil infiltration in inflamed tissue. Camphor affects inflammatory response only after oral administration. It exerts antiinflammatory effects at low doses but has an irritant effect at higher doses. Further studies are needed to elucidate the mechanism of the action of camphor.
